Novel cathepsin-X inhibitors and their ability to improve cathepsin B-directed antitumor therapy

Colleges for Department of pharmaceutical biology and Department of pharmaceutical chemistry together with colleges from Jožef Stefan Institute published the paper in journal Cellular and Molecular Life Science (IF = 9.261) entitled “Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy”. More...

10. January 2022